SciELO - Scientific Electronic Library Online

 
vol.134 issue6Hepatitis C in Chile: Burden of the disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

NOGALES-GAETE, Jorge; ARRIAGADA R, Camilo  and  SALINAS R, Rodrigo. Treatment of neurocysticercosis: A review. Rev. méd. Chile [online]. 2006, vol.134, n.6, pp.789-796. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000600017.

Neurocysticercosis (NCC) is the most common parasitic disease of the central nervous system. Several drugs, such as drugs against tapeworms, praziquantel or albendazole associated to corticosteroids, have been tested for the treatment of this condition. Although some have claimed the reduction or involution of cystic or granulomatous lesions, there is no consensus about the efficacy of these treatments. The natural evolution of the disease is not clear and this hampers the assessment of treatment effects. Moreover, there are no good imaging or clinical indicators that can predict the progression or spontaneous resolution of lesions, specially at the meningeal or ventricular compartment. Therefore, evidence based medicine does not have a definitive answer about the treatment, neither of seizures, the most common manifestation of NCC, or the varied and complex meningeal and ventricular involvement. This review includes experts opinions to give the clinician some clues for decision making in the treatment of NCC

Keywords : Albendazole; Neurocysticercosis; Praziquantel; Treatment.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License